31 related articles for article (PubMed ID: 8249114)
1. Peripheral tissular analysis of rapamycin's effect as a neuroprotective agent in vivo.
Gonzalez-Alcocer A; Gopar-Cuevas Y; Soto-Dominguez A; Loera-Arias MJ; Saucedo-Cardenas O; Montes de Oca-Luna R; Rodriguez-Rocha H; Garcia-Garcia A
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1239-1255. PubMed ID: 35895156
[TBL] [Abstract][Full Text] [Related]
2. Engineering the vasculature for islet transplantation.
Bowers DT; Song W; Wang LH; Ma M
Acta Biomater; 2019 Sep; 95():131-151. PubMed ID: 31128322
[TBL] [Abstract][Full Text] [Related]
3. Local release of rapamycin by microparticles delays islet rejection within the anterior chamber of the eye.
Fan Y; Zheng X; Ali Y; Berggren PO; Loo SCJ
Sci Rep; 2019 Mar; 9(1):3918. PubMed ID: 30850640
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract.
Baluk P; Yao LC; Flores JC; Choi D; Hong YK; McDonald DM
JCI Insight; 2017 Aug; 2(16):. PubMed ID: 28814666
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 pathway mediates beta cell compensatory proliferation in 60 % partial-pancreatectomy mice.
Li W; Zhang H; Nie A; Ni Q; Li F; Ning G; Li X; Gu Y; Wang Q
Endocrine; 2016 Jul; 53(1):117-28. PubMed ID: 26818915
[TBL] [Abstract][Full Text] [Related]
6. Cell biology. On being the right (cell) size.
Ginzberg MB; Kafri R; Kirschner M
Science; 2015 May; 348(6236):1245075. PubMed ID: 25977557
[TBL] [Abstract][Full Text] [Related]
7. Assessing the effect of immunosuppression on engraftment of pancreatic islets.
Vallabhajosyula P; Hirakata A; Shimizu A; Okumi M; Tchipashvili V; Hong H; Yamada K; Sachs DH
Transplantation; 2013 Aug; 96(4):372-8. PubMed ID: 23883972
[TBL] [Abstract][Full Text] [Related]
8. Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.
Barlow AD; Nicholson ML; Herbert TP
Diabetes; 2013 Aug; 62(8):2674-82. PubMed ID: 23881200
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2).
Barlow AD; Xie J; Moore CE; Campbell SC; Shaw JA; Nicholson ML; Herbert TP
Diabetologia; 2012 May; 55(5):1355-65. PubMed ID: 22314813
[TBL] [Abstract][Full Text] [Related]
10. The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.
Xie J; Herbert TP
Cell Mol Life Sci; 2012 Apr; 69(8):1289-304. PubMed ID: 22068611
[TBL] [Abstract][Full Text] [Related]
11. Macrophages are not the source of injurious interleukin-18 in ischemic acute kidney injury in mice.
He Z; Dursun B; Oh DJ; Lu L; Faubel S; Edelstein CL
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F535-42. PubMed ID: 19129255
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs.
Cross SE; Richards SK; Clark A; Benest AV; Bates DO; Mathieson PW; Johnson PR; Harper SJ; Smith RM
Diabetologia; 2007 Jul; 50(7):1423-32. PubMed ID: 17476476
[TBL] [Abstract][Full Text] [Related]
13. [Diabetes and heart transplantation].
Loebe M; Ramasubbu K; Hamilton DJ
Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i48-53. PubMed ID: 16598548
[TBL] [Abstract][Full Text] [Related]
14. Benefit-risk assessment of sirolimus in renal transplantation.
Kuypers DR
Drug Saf; 2005; 28(2):153-81. PubMed ID: 15691225
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant diabetes mellitus. The role of immunosuppression.
Jindal RM; Sidner RA; Milgrom ML
Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies.
Fabian MC; Lakey JR; Rajotte RV; Kneteman NM
Transplantation; 1993 Nov; 56(5):1137-42. PubMed ID: 8249114
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin prolongs murine islet allograft survival.
Fabian MC; Lakey JR; Rajotte RV; Kneteman NM
Transplant Proc; 1992 Dec; 24(6):2842. PubMed ID: 1465966
[No Abstract] [Full Text] [Related]
18. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
19. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
